BL-M17D1

Other Medications

EU Experimental ES Not available 2 Clinical Trials

Description

BL-M17D1 is an experimental medication currently being studied in clinical trials. It is being investigated as a potential treatment for certain types of cancer, including locally advanced or metastatic gastrointestinal cancers that test positive for or have low expression of HER2. The trials are in Phase 1, which means they are primarily focused on determining the safe dosage and identifying potential side effects. BL-M17D1 is being studied in patients whose cancer has not responded to other treatments or for whom other treatments are not available. The goal is to see if BL-M17D1 is safe and if it shows any signs of effectiveness in these patients. It is not yet approved for use in colorectal cancer or any other cancer.

Mechanism of Action

BL-M17D1 is being studied for its potential to target cancer cells. The specific way it works (its mechanism of action) is still being investigated in clinical trials. It is designed to be used in cancers that express HER2 or have low levels of HER2 expression.

Side Effects

Because BL-M17D1 is an experimental drug in early-phase trials (Phase 1) The full range of potential side effects is still being evaluated. Information about side effects is being collected during the ongoing clinical trials to determine the drug's safety profile. Common side effects in Phase 1 trials can vary widely depending on the drug and the dose But researchers carefully monitor patients for any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT06500052 Phase 1
Recruiting
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
China
NCT06714617 Phase 1
Active, not recruiting
Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
United States

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials2
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.